These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 38330567
1. Prevention of Dialysis Catheter Malfunction with Urokinase and Heparin: A Randomized, Controlled Trial. Wang Q, Jiang N, Chen W, Cheng L, Fu S, Li Q, Li H. Altern Ther Health Med; 2024 Oct; 30(10):218-224. PubMed ID: 38330567 [Abstract] [Full Text] [Related]
6. Safety and efficacy of taurolidine/urokinase versus taurolidine/heparin as a tunneled catheter lock solution in hemodialysis patients: a prospective, randomized, controlled study. Al-Ali F, Hamdy AF, Hamad A, Elsayed M, Zafar Iqbal Z, Elsayed A, Ibrahim R, Tolba H, Buanan H, Fawzy A. Nephrol Dial Transplant; 2018 Apr 01; 33(4):619-626. PubMed ID: 29106676 [Abstract] [Full Text] [Related]
7. Prevention of tunneled cuffed catheter dysfunction with prophylactic use of a taurolidine urokinase lock: A randomized double-blind trial. Bonkain F, Stolear JC, Catalano C, Vandervelde D, Treille S, Couttenye MM, Dhondt A, Libertalis M, Allamani M, Madhoun P, Van Craenenbroeck AH, Vanommeslaeghe F, Van Hulle F, Durieux P, Van Limberghen I, Tielemans C, Wissing KM. PLoS One; 2021 Apr 01; 16(5):e0251793. PubMed ID: 34015014 [Abstract] [Full Text] [Related]
8. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, Luxton G, Moody H. J Am Soc Nephrol; 2002 Aug 01; 13(8):2133-9. PubMed ID: 12138146 [Abstract] [Full Text] [Related]
9. Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction. Thomas CM, Zhang J, Lim TH, Scott-Douglas N, Hons RB, Hemmelgarn BR, Alberta Kidney Disease Network. ASAIO J; 2007 Aug 01; 53(4):485-8. PubMed ID: 17667236 [Abstract] [Full Text] [Related]
10. Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution. Hemmelgarn BR, Manns BJ, Soroka SD, Levin A, MacRae J, Tennankore K, Wilson JS, Weaver RG, Ravani P, Quinn RR, Tonelli M, Kiaii M, Mossop P, Scott-Douglas N. Clin J Am Soc Nephrol; 2018 Mar 07; 13(3):429-435. PubMed ID: 29335321 [Abstract] [Full Text] [Related]
11. Efficacy of urokinase lock to treat thrombotic dysfunction of tunneled hemodialysis catheters: A retrospective cohort study. Van Hulle F, Bonkain F, De Clerck D, Aerden D, Vanwijn I, Tielemans C, Wissing KM. J Vasc Access; 2019 Jan 07; 20(1):60-69. PubMed ID: 29893163 [Abstract] [Full Text] [Related]
14. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Moran J, Sun S, Khababa I, Pedan A, Doss S, Schiller B. Am J Kidney Dis; 2012 Jan 07; 59(1):102-7. PubMed ID: 22088576 [Abstract] [Full Text] [Related]
15. Chronic and acute consequences of a post-dialysis urokinase lock on permanent hemodialysis catheter function. Gabutti L, Mosconi E, Pellegrini L, Duchini F, Marone C. J Nephrol; 2006 Jan 07; 19(2):183-8. PubMed ID: 16736417 [Abstract] [Full Text] [Related]
16. Comparative efficacy and safety of lock solutions for the prevention of catheter-related complications including infectious and bleeding events in adult haemodialysis patients: a systematic review and network meta-analysis. Sheng KX, Zhang P, Li JW, Cheng J, He YC, Böhlke M, Chen JH. Clin Microbiol Infect; 2020 May 07; 26(5):545-552. PubMed ID: 31857208 [Abstract] [Full Text] [Related]
17. [Tesio twin catheter system for hemodialysis tunnelized using an echo-guided technique. Retrospective analysis of 210 catheters]. Ibrik O, Samon R, Roca R, Viladoms J, Mora J. Nefrologia; 2006 May 07; 26(6):719-25. PubMed ID: 17227250 [Abstract] [Full Text] [Related]